Headless Compression Screws Market By Type (Fully Threaded Screw, Both Ends Threaded Screw) , By Application (Hand, Wrist, Foot, Ankle, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Headless Compression Screws Market
The headless compression screws market was valued at $354.0 million in 2023 and is projected to reach $547.9 million by 2033, growing at a CAGR of 4.5% from 2024 to 2033.
A headless compression screw is implanted in fractures to stabilize the bones around joint structures. It is either implanted percutaneously via stab incision or through an elaborate open procedure. The commonly utilized sizes of headless compression screws are 2.4 and 3.0 mm. Their headless configuration reduces interference with surrounding tissues and minimizes the risk of infection & pressure sores. Most of the headless compression screws are cannulated in shape and hence require a guide wire for insertion.
Exponential growth in the elderly population globally has led to rise in prevalence of fractures and orthopedic injuries, driving the development of the headless compression screws market. In addition, improvements in screw designs have promoted their usage for treatments and propelled the market growth due to improved patient outcomes & quick recovery times. Furthermore, rise in the number of individuals pursuing sports as a career or for relaxation purposes has caused an increase in related injuries, augmenting the growth of the market. A notable trend acquiring traction in the market is the use of bioresorbable materials in screw formation. These screws dissolve in the body after a specific period, eliminating the hassle of their removal after patient recovery.
However, high cost of headless compression screws and surgeries requiring them deters several budget-sensitive individuals from undergoing the treatment, hampering the development of the market. Moreover, possible complications associated with the screws such as nonunion or malunion hamper the market growth significantly. On the contrary, personalization of treatments for every patient by engineering the screws as per their unique anatomy and injury is poised to present lucrative opportunities for the market. Furthermore, the rise of additive manufacturing is expected to fuel this trend of personalized treatment and present new avenues for the headless compression screws market.
Segment ReviewThe headless compression screws market is segmented into type, application, and region. Depending on type, it is bifurcated into fully threaded screw and both ends threaded screw. As per application, it is classified into hand, wrist, foot, ankle, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key FindingsDepending on type, the fully threaded screw segment is projected to account for a high share of the market during the forecast period.
As per application, the ankle segment is anticipated to acquire a high stake in the market throughout the forecast period.
Region wise, North America is expected to be the highest revenue generator by 2033.
Competition AnalysisThe major players operating in the global headless compression screws market include Johnson & Johnson, Zimmer Biomet Holding, Inc., Smith & Nephew plc, Stryker Corporation, Acumed Ltd., MEDARTIS AG, Orthofix Holdings, Inc., Integra Lifesciences Corporation, Wright Medical Group N.V, and Arthrex, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Key Market SegmentsBy TypeFully Threaded Screw
Both Ends Threaded Screw
By ApplicationHand
Wrist
Foot
Ankle
Others
By RegionNorth America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market PlayersJohnson & Johnson
Zimmer Biomet Holding, Inc.
Smith & Nephew plc
Stryker Corporation.
acumed ltd
MEDARTIS AG
Orthofix Holdings, Inc.
Integra Lifesciences Corporation.
Wright Medical Group N.V
Arthrex, Inc.